Biosigma: Biotechnology and Clinical Chemistry
Conventional plastics, especially those from non-renewable sources, pose a challenge to the environment due to their limited biodegradability.
Laboratories can mitigate their impact by integrating bio-based materials and adopting environmentally friendly practices that minimize their plastic footprint. Committed to innovation and sustainability, Biosigma has embraced the Mass Balance Model, integrating circular feedstocks into its production facilities.
As a pioneer in innovation, Biosigma introduces the BIOBased CLEARLine® products, which are manufactured with at least 90% certified plastic from bio-based raw materials. All our BIOBased products are supplied in bulk bags to minimize packaging waste and reduce their environmental impact.
During this process, the properties of the polymer and the product remain compliant with the existing specifications. Such a sustainable approach not only preserves product integrity, but also contributes to significant emission savings, in line with our commitment to a greener future.
Our BIOBased® CLEARLine® products have been reassessed under the updated My Green Lab® ACT® Ecolabel 2.0 Standard.
ACT Ecolabel 2.0 introduces a weighted, science-based 100-point Environmental Performance Factor score and expanded transparency across product materials, packaging, manufacturing practices, greenhouse gas reductions and available product carbon footprint data.
All sustainability claims and data are independently verified through third-party auditing, helping laboratories and procurement teams make more informed purchasing decisions.
Each piece is designed to meet the most demanding needs ensuring precision and safety. We provide a complete range of laboratory consumables and equipment for Research, Biotechnology and Health sectors.
